Coil Embolization of Coronary Artery Fistulas

This study has been completed.
Sponsor:
Information provided by:
HOSPITEN
ClinicalTrials.gov Identifier:
NCT00198016
First received: September 12, 2005
Last updated: October 16, 2008
Last verified: August 2005
  Purpose

Background and Purpose: Congenital coronary artery fistula (CAF) is an uncommon anomaly. In some patients they can became symptomatic, associated with significant morbidity and mortality. We report our experience in percutaneous treatment of CAF.


Condition Intervention Phase
C14
C14907933
C14907933125
G09330582163324
C14280647250
Device: Coil
Phase 4

Study Type: Observational
Official Title: Coil Embolization of Coronary Artery Fistulas: A Single Centre Experience

Resource links provided by NLM:


Further study details as provided by HOSPITEN:

Study Start Date: January 2004
Estimated Study Completion Date: August 2005
Detailed Description:

Congenital coronary artery fistula (CAF) can be defined as a direct communication of a coronary artery with a cardiac chamber, great vessel, or other vascular structure, bypassing the myocardial capillary bed.

CAF is an uncommon anomaly, occurring as an incidental finding in 0.1% to 0.2% of coronary angiograms. They are not gender specific. Many patients have symptoms like congestive heart failure, infective endocarditis, myocardial ischemia, or rupture of an aneurismal fistula. Surgical closure of coronary artery fistula was initially reported in 1983 with low rates of morbidity and mortality.

Percutaneous treatment appeared as an alternative to surgery. Transcatheter closure of CAF was first utilized in 1983. Along this years, with experience and improvements in catheterization equipment and occlusion devices, CAF occlusion have been successfully performed using microcoils.

We report our experience in using microcoils to percutaneous treatment of coronary fistulas.

  Eligibility

Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Coronary artery fistulas
  • Clinical diagnosis of angina, myocardial infarction, left ventricular insufficiency, ventricular enlargement

Exclusion Criteria:

  • Age <18 or > 85 years
  • Cardiogenic shock _ severe ventricular enlargement
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00198016

Locations
Spain
HOSPITEN
Santa Cruz, Tenerife, Spain, 38001
Sponsors and Collaborators
HOSPITEN
Investigators
Study Director: Zuheir Kabbani, Cardiology HOSPITEN
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00198016     History of Changes
Other Study ID Numbers: HOSPITEN
Study First Received: September 12, 2005
Last Updated: October 16, 2008
Health Authority: Spain: Ministry of Health

Keywords provided by HOSPITEN:
coronary fistulas.
coils embolization.

Additional relevant MeSH terms:
Fistula
Pathological Conditions, Anatomical

ClinicalTrials.gov processed this record on August 27, 2014